Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Changes in antimicrobial resistance of clinical isolates of Acinetobacter baumannii group isolated in Greece, 2010-2015.

Dafopoulou K, Tsakris A, Pournaras S.

J Med Microbiol. 2018 Apr;67(4):496-498. doi: 10.1099/jmm.0.000708. Epub 2018 Mar 5.

PMID:
29504930
2.

Dissemination of linezolid-dependent, linezolid-resistant Staphylococcus epidermidis clinical isolates belonging to CC5 in German hospitals.

Layer F, Vourli S, Karavasilis V, Strommenger B, Dafopoulou K, Tsakris A, Werner G, Pournaras S.

J Antimicrob Chemother. 2018 May 1;73(5):1181-1184. doi: 10.1093/jac/dkx524.

PMID:
29360979
3.

Evaluation of two automated systems for colistin susceptibility testing of carbapenem-resistant Acinetobacter baumannii clinical isolates.

Vourli S, Dafopoulou K, Vrioni G, Tsakris A, Pournaras S.

J Antimicrob Chemother. 2017 Sep 1;72(9):2528-2530. doi: 10.1093/jac/dkx186.

PMID:
28605445
4.

Predominance of international clone 2 OXA-23-producing-Acinetobacter baumannii clinical isolates in Greece, 2015: results of a nationwide study.

Pournaras S, Dafopoulou K, Del Franco M, Zarkotou O, Dimitroulia E, Protonotariou E, Poulou A, Zarrilli R, Tsakris A; Greek Study Group on Acinetobacter Antimicrobial Resistance.

Int J Antimicrob Agents. 2017 Jun;49(6):749-753. doi: 10.1016/j.ijantimicag.2017.01.028. Epub 2017 Apr 18.

PMID:
28427842
5.

Reply to "Reliability of Gradient Diffusion Methods for Detection of Acquired Colistin Resistance".

Dafopoulou K, Zarkotou O, Dimitroulia E, Hadjichristodoulou C, Gennimata V, Pournaras S, Tsakris A.

Antimicrob Agents Chemother. 2016 Jun 20;60(7):4424-5. doi: 10.1128/AAC.00206-16. Print 2016 Jul. No abstract available.

6.

Colistin-Resistant Acinetobacter baumannii Clinical Strains with Deficient Biofilm Formation.

Dafopoulou K, Xavier BB, Hotterbeekx A, Janssens L, Lammens C, Dé E, Goossens H, Tsakris A, Malhotra-Kumar S, Pournaras S.

Antimicrob Agents Chemother. 2015 Dec 14;60(3):1892-5. doi: 10.1128/AAC.02518-15.

7.

Comparative Evaluation of Colistin Susceptibility Testing Methods among Carbapenem-Nonsusceptible Klebsiella pneumoniae and Acinetobacter baumannii Clinical Isolates.

Dafopoulou K, Zarkotou O, Dimitroulia E, Hadjichristodoulou C, Gennimata V, Pournaras S, Tsakris A.

Antimicrob Agents Chemother. 2015 Aug;59(8):4625-30. doi: 10.1128/AAC.00868-15. Epub 2015 May 26.

8.

Single-locus-sequence-based typing of blaOXA-51-like genes for rapid assignment of Acinetobacter baumannii clinical isolates to international clonal lineages.

Pournaras S, Gogou V, Giannouli M, Dimitroulia E, Dafopoulou K, Tsakris A, Zarrilli R.

J Clin Microbiol. 2014 May;52(5):1653-7. doi: 10.1128/JCM.03565-13. Epub 2014 Mar 12.

9.

Growth retardation, reduced invasiveness, and impaired colistin-mediated cell death associated with colistin resistance development in Acinetobacter baumannii.

Pournaras S, Poulou A, Dafopoulou K, Chabane YN, Kristo I, Makris D, Hardouin J, Cosette P, Tsakris A, Dé E.

Antimicrob Agents Chemother. 2014;58(2):828-32. doi: 10.1128/AAC.01439-13. Epub 2013 Nov 18.

10.

The indoleamine 2,3-dioxygenase inhibitor 1-methyl-tryptophan suppresses mitochondrial function, induces aerobic glycolysis and decreases interleukin-10 production in human lymphocytes.

Eleftheriadis T, Pissas G, Karioti A, Antoniadi G, Liakopoulos V, Dafopoulou K, Pournaras S, Koukoulis G, Stefanidis I.

Immunol Invest. 2012;41(5):507-20. doi: 10.3109/08820139.2012.682244. Epub 2012 May 17.

PMID:
22594922

Supplemental Content

Loading ...
Support Center